Christopher M. Raskett

1.2k total citations
25 papers, 992 citations indexed

About

Christopher M. Raskett is a scholar working on Molecular Biology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher M. Raskett has authored 25 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Neurology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher M. Raskett's work include Intracranial Aneurysms: Treatment and Complications (7 papers), Cerebrovascular and Carotid Artery Diseases (4 papers) and Aortic aneurysm repair treatments (4 papers). Christopher M. Raskett is often cited by papers focused on Intracranial Aneurysms: Treatment and Complications (7 papers), Cerebrovascular and Carotid Artery Diseases (4 papers) and Aortic aneurysm repair treatments (4 papers). Christopher M. Raskett collaborates with scholars based in United States, France and Italy. Christopher M. Raskett's co-authors include Dario C. Altieri, Takehiko Dohi, Lucia R. Languino, Markus D. Siegelin, Swarna Mehrotra, Arthur M. Mercurio, Janet Plescia, Alonzo H. Ross, Candace A. Gilbert and Igor Prudovsky and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Christopher M. Raskett

25 papers receiving 979 citations

Peers

Christopher M. Raskett
Anu Gupta United States
Anjan K. Pradhan United States
Garrett T. Graham United States
Dhruv K. Pant United States
Sherry A. Weppler Netherlands
Anu Gupta United States
Christopher M. Raskett
Citations per year, relative to Christopher M. Raskett Christopher M. Raskett (= 1×) peers Anu Gupta

Countries citing papers authored by Christopher M. Raskett

Since Specialization
Citations

This map shows the geographic impact of Christopher M. Raskett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Raskett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Raskett more than expected).

Fields of papers citing papers by Christopher M. Raskett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Raskett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Raskett. The network helps show where Christopher M. Raskett may publish in the future.

Co-authorship network of co-authors of Christopher M. Raskett

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Raskett. A scholar is included among the top collaborators of Christopher M. Raskett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Raskett. Christopher M. Raskett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
King, R, Mohammed Salman Shazeeb, Mark Epshtein, et al.. (2024). Selective brain cooling with a novel catheter reduces infarct growth after recanalization in a canine large vessel occlusion model. Interventional Neuroradiology. 3994342234–3994342234. 1 indexed citations
2.
Benatti, Hector Ribeiro, Toloo Taghian, Carl B. Heilman, et al.. (2024). A minimally invasive endovascular approach to the cerebellopontine angle cistern enables broad CNS biodistribution of scAAV9-CB-GFP. Molecular Therapy. 32(10). 3346–3355. 2 indexed citations
3.
King, R, Mark Epshtein, Christopher M. Raskett, et al.. (2023). Active drug-coated flow diverter in a preclinical model of intracranial stenting. Journal of NeuroInterventional Surgery. 16(7). 731–736. 7 indexed citations
4.
Procopio, Emanuele, Mark Epshtein, Christopher M. Raskett, et al.. (2023). Development of a clot-adhesive coating to improve the performance of thrombectomy devices. Journal of NeuroInterventional Surgery. 15(12). 1207–1211. 4 indexed citations
5.
King, R, Vania Anagnostakou, Christopher M. Raskett, et al.. (2022). High-frequency optical coherence tomography predictors of aneurysm occlusion following flow diverter treatment in a preclinical model. Journal of NeuroInterventional Surgery. 15(9). 919–923. 7 indexed citations
6.
King, R, Erin Langan, Giovanni J. Ughi, et al.. (2020). Acute Thrombus Burden on Coated Flow Diverters Assessed by High Frequency Optical Coherence Tomography. CardioVascular and Interventional Radiology. 43(8). 1218–1223. 10 indexed citations
7.
King, R, Jildaz Caroff, Erin Langan, et al.. (2020). In situ decellularization of a large animal saccular aneurysm model: sustained inflammation and active aneurysm wall remodeling. Journal of NeuroInterventional Surgery. 13(3). 267–271. 5 indexed citations
8.
Caroff, Jildaz, R King, Giovanni J. Ughi, et al.. (2020). Longitudinal Monitoring of Flow-Diverting Stent Tissue Coverage After Implant in a Bifurcation Model Using Neurovascular High-Frequency Optical Coherence Tomography. Neurosurgery. 87(6). 1311–1319. 12 indexed citations
9.
Marosföi, Miklós, Jildaz Caroff, R King, et al.. (2019). Complete clot ingestion with cyclical ADAPT increases first-pass recanalization and reduces distal embolization. Journal of NeuroInterventional Surgery. 11(9). 931–936. 51 indexed citations
10.
King, R, Erin Langan, Mohammed Salman Shazeeb, et al.. (2019). P-026 The use of high-frequency optical coherence tomography for follow-up imaging of treated aneurysms. A39.2–A40. 1 indexed citations
11.
Marosföi, Miklós, Lara Strittmatter, Christopher M. Raskett, et al.. (2019). E-112 How do clots respond to direct aspiration during interventional treatment of acute ischemic stroke. A109.2–A110. 2 indexed citations
12.
Kang, Byoung Heon, Michele Tavecchio, Hira Lal Goel, et al.. (2011). Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease. British Journal of Cancer. 104(4). 629–634. 48 indexed citations
13.
Siegelin, Markus D., Takehiko Dohi, Christopher M. Raskett, et al.. (2011). Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. Journal of Clinical Investigation. 121(4). 1349–1360. 136 indexed citations
14.
Xia, Fang, Takehiko Dohi, Nina Martin, et al.. (2011). Essential Role of the Small GTPase Ran in Postnatal Pancreatic Islet Development. PLoS ONE. 6(11). e27879–e27879. 9 indexed citations
15.
Siegelin, Markus D., Janet Plescia, Christopher M. Raskett, et al.. (2010). Global Targeting of Subcellular Heat Shock Protein-90 Networks for Therapy of Glioblastoma. Molecular Cancer Therapeutics. 9(6). 1638–1646. 34 indexed citations
16.
Siegelin, Markus D., Christopher M. Raskett, Candace A. Gilbert, Alonzo H. Ross, & Dario C. Altieri. (2010). Sorafenib exerts anti-glioma activity in vitro and in vivo. Neuroscience Letters. 478(3). 165–170. 65 indexed citations
17.
Mehrotra, Swarna, Lucia R. Languino, Christopher M. Raskett, et al.. (2010). IAP Regulation of Metastasis. Cancer Cell. 17(1). 53–64. 249 indexed citations
18.
Guha, Minakshi, Fang Xia, Christopher M. Raskett, & Dario C. Altieri. (2009). Caspase 2-mediated tumor suppression involves survivin gene silencing. Oncogene. 29(9). 1280–1292. 26 indexed citations
19.
Ghosh, Jagadish C., Takehiko Dohi, Christopher M. Raskett, Timothy F. Kowalik, & Dario C. Altieri. (2006). Activated Checkpoint Kinase 2 Provides a Survival Signal for Tumor Cells. Cancer Research. 66(24). 11576–11579. 56 indexed citations
20.
Gyurkocza, Boglarka, Janet Plescia, Christopher M. Raskett, et al.. (2006). Antileukemic Activity of Shepherdin and Molecular Diversity of Hsp90 Inhibitors. JNCI Journal of the National Cancer Institute. 98(15). 1068–1077. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026